Screener
Regeneron Pharmaceuticals REGN Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Regeneron Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The source filing: Regeneron Pharmaceuticals’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 6:52 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000872589-26-000025
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Long-term debt | 1,986.6 | 1,985.9 |
| Finance lease liabilities | — | 720.0 |
| Deferred revenue | 220.4 | 208.7 |
| Other noncurrent liabilities | 2,281.6 | 2,018.8 |
| Total liabilities | 10,019.2 | 9,301.8 |
| Stockholders' equity: | ||
| Preferred Stock, par value $.01 per share; 30.0 shares authorized; shares issued and outstanding - none | — | — |
| Class A Stock, convertible, par value $.001 per share; 40.0 shares authorized; shares issued and outstanding - 1.8 in 2026 and 2025 | — | — |
Item 1. Financial Statements (unaudited)
FAQ
- What is Regeneron Pharmaceuticals's other non-current liabilities?
- Regeneron Pharmaceuticals (REGN) reported other non-current liabilities of $2.28B in Q2 2026.
- How has Regeneron Pharmaceuticals's other non-current liabilities changed year-over-year?
- Regeneron Pharmaceuticals's other non-current liabilities increased by 34.1% year-over-year, from $1.7B to $2.28B.
- What is the long-term trend for Regeneron Pharmaceuticals's other non-current liabilities?
- Over 5 years (2020 to 2025), Regeneron Pharmaceuticals's other non-current liabilities has grown at a 24.1% compound annual growth rate (CAGR), from $687.1M to $2.02B.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.
Ask your AI about Regeneron Pharmaceuticals's other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude